nandrolone has been researched along with gestodene in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Göretzlehner, G; Köhler, G | 1 |
| Joosten, JW; Kloosterboer, HJ; Schoonen, WG | 2 |
| Borja-Cacho, E; Cooney, AJ; García-Becerra, R; Larrea, F; Lemus, AE; Pérez-Palacios, G | 1 |
| Calagna, G; Colacurci, N; Cucinella, G; De Franciscis, P; Granese, R; Perino, A; Saitta, S; Svelato, A; Tonni, G | 1 |
| Bannemerschult, R; Endrikat, J; Gerlinger, C; Marr, J; Mellinger, U; Merz, M; Schellschmidt, I; Trussell, J | 1 |
1 review(s) available for nandrolone and gestodene
| Article | Year |
|---|---|
[New progestational hormones].
Topics: Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Nandrolone; Norgestrel; Norpregnenes; Progesterone Congeners | 1988 |
2 trial(s) available for nandrolone and gestodene
| Article | Year |
|---|---|
Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference?
Topics: Adolescent; Adult; Combined Modality Therapy; Contraceptives, Oral; Desogestrel; Drug Administration Schedule; Endometriosis; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Laparoscopy; Nandrolone; Norpregnenes; Ovarian Diseases; Secondary Prevention; Treatment Outcome; Young Adult | 2013 |
Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.
Topics: Adult; Androstenes; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Estradiol; Ethinyl Estradiol; Europe; Female; Humans; Intention to Treat Analysis; Matched-Pair Analysis; Nandrolone; Norpregnenes; Pregnancy; Pregnancy, Unwanted; Progestins; Risk Assessment; South America; Transdermal Patch; United States; Young Adult | 2014 |
3 other study(ies) available for nandrolone and gestodene
| Article | Year |
|---|---|
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Desogestrel; Estradiol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Statistical; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 1995 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured | 1995 |
Comparative evaluation of androgen and progesterone receptor transcription selectivity indices of 19-nortestosterone-derived progestins.
Topics: Androgens; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Genes, Reporter; Genetic Vectors; HeLa Cells; Humans; Levonorgestrel; Ligands; Nandrolone; Norethindrone; Norpregnenes; Plasmids; Progestins; Protein Biosynthesis; Receptors, Androgen; Receptors, Progesterone; Transcription, Genetic; Transcriptional Activation; Transfection; Trypsin | 2004 |